{"status": "ok", "message-type": "work-list", "message-version": "1.0.0", "message": {"facets": {}, "total-results": 246, "items": [{"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T13:41:34Z", "timestamp": 1575466894219}, "reference-count": 55, "publisher": "The American Association of Immunologists", "issue": "9", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J Immunol"], "published-print": {"date-parts": [[2001, 5, 1]]}, "DOI": "10.4049/jimmunol.166.9.5480", "type": "journal-article", "created": {"date-parts": [[2014, 4, 20]], "date-time": "2014-04-20T23:42:04Z", "timestamp": 1398037324000}, "page": "5480-5487", "source": "Crossref", "is-referenced-by-count": 136, "title": ["CD150 Association with Either the SH2-Containing Inositol Phosphatase or the SH2-Containing Protein Tyrosine Phosphatase Is Regulated by the Adaptor Protein SH2D1A"], "prefix": "10.4049", "volume": "166", "author": [{"given": "Larysa M.", "family": "Shlapatska", "sequence": "first", "affiliation": []}, {"given": "Svitlana V.", "family": "Mikhalap", "sequence": "additional", "affiliation": []}, {"given": "Anna G.", "family": "Berdova", "sequence": "additional", "affiliation": []}, {"given": "Oleksander M.", "family": "Zelensky", "sequence": "additional", "affiliation": []}, {"given": "Theodore J.", "family": "Yun", "sequence": "additional", "affiliation": []}, {"given": "Kim E.", "family": "Nichols", "sequence": "additional", "affiliation": []}, {"given": "Edward A.", "family": "Clark", "sequence": "additional", "affiliation": []}, {"given": "Svetlana P.", "family": "Sidorenko", "sequence": "additional", "affiliation": []}], "member": "2487", "published-online": {"date-parts": [[2001, 5, 1]]}, "reference": [{"key": "2019061817341865000_166.9.5480.1", "DOI": "10.1146/annurev.immunol.16.1.645", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.2", "DOI": "10.1016/S0065-2776(08)60786-5", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.3", "volume": "151", "first-page": "4614", "year": "1993", "journal-title": "J. Immunol."}, {"key": "2019061817341865000_166.9.5480.4", "DOI": "10.1038/376260a0", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.5", "volume": "162", "first-page": "5719", "year": "1999", "journal-title": "J. Immunol."}, {"key": "2019061817341865000_166.9.5480.6", "DOI": "10.1084/jem.185.6.993", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.7", "volume": "158", "first-page": "4036", "year": "1997", "journal-title": "J. Immunol."}, {"key": "2019061817341865000_166.9.5480.8", "DOI": "10.1016/S0022-1759(00)00200-3", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.9", "DOI": "10.1038/icb.1997.30", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.10", "DOI": "10.1038/26683", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.11", "volume": "163", "first-page": "5860", "year": "1999", "journal-title": "J. Immunol."}, {"key": "2019061817341865000_166.9.5480.12", "DOI": "10.1038/2424", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.13", "DOI": "10.1073/pnas.95.23.13765", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.14", "DOI": "10.1016/S0952-7915(99)80072-7", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.15", "DOI": "10.1016/S1097-2765(00)80206-3", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.16", "DOI": "10.1016/S0960-9822(00)80080-9", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.17", "volume": "162", "first-page": "6981", "year": "1999", "journal-title": "J. Immunol."}, {"key": "2019061817341865000_166.9.5480.18", "DOI": "10.4049/jimmunol.165.6.2932", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.19", "DOI": "10.1084/jem.192.3.337", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.20", "DOI": "10.1093/hmg/8.13.2407", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.21", "DOI": "10.1046/j.1365-2141.2000.01884.x", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.22", "volume": "39", "first-page": "3", "year": "1992", "journal-title": "Neoplasma"}, {"key": "2019061817341865000_166.9.5480.23", "DOI": "10.1073/pnas.83.12.4494", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.24", "DOI": "10.1016/0378-1119(89)90358-2", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.25", "volume": "16", "first-page": "1305", "year": "1996", "journal-title": "Mol. Cell. Biol.", "DOI": "10.1128/MCB.16.4.1305", "doi-asserted-by": "crossref"}, {"key": "2019061817341865000_166.9.5480.26", "volume": "269", "first-page": "12310", "year": "1994", "journal-title": "J. Biol. Chem."}, {"key": "2019061817341865000_166.9.5480.27", "DOI": "10.1016/S1074-7613(00)80261-7", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.28", "DOI": "10.1084/jem.183.2.547", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.29", "volume": "3", "first-page": "114", "year": "1995", "journal-title": "Proc. Int. Conf. Intell. Syst. Mol. Biol."}, {"key": "2019061817341865000_166.9.5480.30", "DOI": "10.1093/bioinformatics/14.9.755", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.31", "volume": "4", "first-page": "155", "year": "1996", "journal-title": "Proc. Int. Conf. Intell. Syst. Mol. Biol."}, {"key": "2019061817341865000_166.9.5480.32", "volume": "1", "first-page": "134", "year": "1997", "journal-title": "Proteins Suppl."}, {"key": "2019061817341865000_166.9.5480.33", "DOI": "10.1093/bioinformatics/14.10.846", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.34", "DOI": "10.1016/S0968-0004(99)01427-9", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.35", "DOI": "10.1002/elps.1150181505", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.36", "DOI": "10.1002/pro.5560020916", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.37", "DOI": "10.1038/356083a0", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.38", "DOI": "10.1038/35000501", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.39", "DOI": "10.1016/S0952-7915(99)80042-9", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.40", "DOI": "10.1016/S0952-7915(99)80040-5", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.41", "DOI": "10.1146/annurev.immunol.17.1.875", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.42", "DOI": "10.1016/S0952-7915(99)80041-7", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.43", "DOI": "10.1016/S0014-5793(99)00446-9", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.44", "DOI": "10.1038/35022579", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.45", "volume": "68", "first-page": "4525", "year": "1994", "journal-title": "J. Virol."}, {"key": "2019061817341865000_166.9.5480.46", "DOI": "10.1084/jem.189.8.1181", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.47", "DOI": "10.1016/S0167-5699(99)01519-4", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.48", "DOI": "10.1093/bioinformatics/13.2.191", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.49", "DOI": "10.1016/S0092-8674(00)80938-1", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.50", "volume": "244", "first-page": "43", "year": "1999", "journal-title": "Curr. Top. Microbiol. Immunol."}, {"key": "2019061817341865000_166.9.5480.51", "DOI": "10.1016/S0165-2478(99)00027-9", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.52", "DOI": "10.1016/S0092-8674(00)80337-2", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.53", "DOI": "10.1084/jem.188.7.1333", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.54", "DOI": "10.1084/jem.191.5.781", "doi-asserted-by": "publisher"}, {"key": "2019061817341865000_166.9.5480.55", "DOI": "10.1002/1097-0215(20001101)88:3<439::AID-IJC17>3.0.CO;2-#", "doi-asserted-by": "publisher"}], "container-title": ["The Journal of Immunology"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.4049/jimmunol.166.9.5480", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 6, 19]], "date-time": "2019-06-19T01:02:55Z", "timestamp": 1560906175000}, "score": 124.30891, "issued": {"date-parts": [[2001, 5, 1]]}, "references-count": 55, "journal-issue": {"published-online": {"date-parts": [[2001, 5, 1]]}, "published-print": {"date-parts": [[2001, 5, 1]]}, "issue": "9"}, "alternative-id": ["10.4049/jimmunol.166.9.5480"], "URL": "http://dx.doi.org/10.4049/jimmunol.166.9.5480", "relation": {"cites": []}, "ISSN": ["0022-1767", "1550-6606"], "issn-type": [{"value": "0022-1767", "type": "print"}, {"value": "1550-6606", "type": "electronic"}], "subject": ["Immunology"]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:41:08Z", "timestamp": 1574134868093}, "reference-count": 45, "publisher": "American Society of Hematology", "issue": "13", "content-domain": {"domain": ["ashpublications.org"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2004, 12, 15]]}, "abstract": "<jats:title>Abstract</jats:title>\n               <jats:p>The CD150 receptor is expressed on activated T and B lymphocytes, dendritic cells, and monocytes. A TxYxxV/I motif in the CD150 cytoplasmic tail can bind different SH2-containing molecules, including tyrosine and inositol phosphatases, Src family kinases, and adaptor molecules. To analyze CD150-initiated signal transduction pathways, we used DT40 B-cell sublines deficient in these molecules. CD150 ligation on DT40 transfectants induced the extracellular signal-regulated kinase (ERK) pathway, which required SH2-containing inositol phosphatase (SHIP) but not SH2 domain protein 1A (SH2D1A). CD150-mediated Akt phosphorylation required Syk and SH2D1A, was negatively regulated by Lyn and Btk, but was SHIP independent. Lyn directly phosphorylated Y327 in CD150, but the Akt pathway did not depend on CD150 tyrosine phosphorylation and CD150-SHP-2 association. Analysis of CD150 and SH2D1A expression in non-Hodgkin and Hodgkin lymphomas revealed stages of B-cell differentiation where these molecules are expressed alone or coexpressed. Signaling studies in Hodgkin disease cell lines showed that CD150 is linked to the ERK and Akt pathways in neoplastic B cells. Our data support the hypothesis that CD150 and SH2D1A are coexpressed during a narrow window of B-cell maturation and SH2D1A may be involved in regulation of B-cell differentiation via switching of CD150-mediated signaling pathways. (Blood. 2004;104:4063-4070)</jats:p>", "DOI": "10.1182/blood-2004-04-1273", "type": "journal-article", "created": {"date-parts": [[2004, 8, 18]], "date-time": "2004-08-18T01:08:20Z", "timestamp": 1092791300000}, "page": "4063-4070", "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000", "source": "Crossref", "is-referenced-by-count": 22, "title": ["The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells"], "prefix": "10.1182", "volume": "104", "author": [{"given": "Svitlana V.", "family": "Mikhalap", "sequence": "first", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Larysa M.", "family": "Shlapatska", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Olga V.", "family": "Yurchenko", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Maria Y.", "family": "Yurchenko", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Ganna G.", "family": "Berdova", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Kim E.", "family": "Nichols", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Edward A.", "family": "Clark", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}, {"given": "Svetlana P.", "family": "Sidorenko", "sequence": "additional", "affiliation": [{"name": "From the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Sciences Ukraine, Signal Transduction Laboratory, Kiev, Ukraine; the University of Washington, Department of Immunology, Seattle; Children's Hospital of Philadelphia, Department of Pediatric Oncology, Philadelphia, PA."}]}], "member": "234", "reference": [{"key": "2019111701504610100_REF1", "unstructured": "Sidorenko SP, Clark EA. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J Immunol.1993;151: 4614-4624."}, {"key": "2019111701504610100_REF2", "unstructured": "Cocks BG, Chang CC, Carballido JM, et al. A novel receptor involved in T-cell activation. Nature.1995;376: 260-263.", "DOI": "10.1038/376260a0", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF3", "unstructured": "Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol.2003;4: 19-24.", "DOI": "10.1038/ni0103-19", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF4", "unstructured": "Veillette A, Latour S. The SLAM family of immune-cell receptors. Curr Opin Immunol.2003;15: 277-285.", "DOI": "10.1016/S0952-7915(03)00041-4", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF5", "unstructured": "Engel P, Eck MJ, Terhorst C. The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease. Nat Rev Immunol.2003;3: 813-821.", "DOI": "10.1038/nri1202", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF6", "unstructured": "Aversa G, Carballido J, Punnonen J, et al. SLAM and its role in T cell activation and Th cell responses. Immunol Cell Biol.1997;75: 202-205.", "DOI": "10.1038/icb.1997.30", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF7", "unstructured": "Mikhalap SV, Shlapatska LM, Berdova AG, et al. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J Immunol.1999;162: 5719-5727."}, {"key": "2019111701504610100_REF8", "unstructured": "Henning G, Kraft MS, Derfuss T, et al. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity. Eur J Immunol.2001;31: 2741-2750.", "DOI": "10.1002/1521-4141(200109)31:9<2741::AID-IMMU2741>3.0.CO;2-6", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF9", "unstructured": "Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature.2000;406: 893-897.", "DOI": "10.1038/35022579", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF10", "unstructured": "Tatsuo H, Yanagi Y. The morbillivirus receptor SLAM (CD150). Microbiol Immunol.2002;46: 135-142.", "DOI": "10.1111/j.1348-0421.2002.tb02678.x", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF11", "unstructured": "Shlapatska LM, Mikhalap SV, Berdova AG, et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J Immunol.2001;166: 5480-5487.", "DOI": "10.4049/jimmunol.166.9.5480", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF12", "unstructured": "Sayos J, Wu C, Morra M, et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature.1998;395: 462-469.", "DOI": "10.1038/26683", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF13", "unstructured": "Latour S, Gish G, Helgason CD, et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nat Immunol.2001;2: 681-690.", "DOI": "10.1038/90615", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF14", "unstructured": "Morra M, Howie D, Grande MS, et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu Rev Immunol.2001;19: 657-682.", "DOI": "10.1146/annurev.immunol.19.1.657", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF15", "unstructured": "Latour S, Roncagalli R, Chen R, et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nat Cell Biol.2003;5: 149-154.", "DOI": "10.1038/ncb919", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF16", "unstructured": "Chan B, Lanyi A, Song HK, et al. SAP couples Fyn to SLAM immune receptors. Nat Cell Biol.2003;5: 155-160.", "DOI": "10.1038/ncb920", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF17", "unstructured": "Li C, Iosef C, Jia CY, Han VK, Li SS. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J Biol Chem.2003;278: 3852-3859.", "DOI": "10.1074/jbc.M206649200", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF18", "unstructured": "Nichols KE, Harkin DP, Levitz S, et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci U S A.1998;95: 13765-13770.", "DOI": "10.1073/pnas.95.23.13765", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF19", "unstructured": "Arico M, Imashuku S, Clementi R, et al. Hemophagocytic lymphohistiocytosis due to germline mutations in SH2D1A, the X-linked lymphoproliferative disease gene. Blood.2001;97: 1131-1133.", "DOI": "10.1182/blood.V97.4.1131", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF20", "unstructured": "Coffey AJ, Brooksbank RA, Brandau O, et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet.1998;20: 129-135.", "DOI": "10.1038/2424", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF21", "unstructured": "Tangye SG, Lazetic S, Woollatt E, et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol.1999;162: 6981-6985."}, {"key": "2019111701504610100_REF22", "unstructured": "Nagy N, Mattsson K, Maeda A, et al. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells. Immunol Lett.2002;82: 141-147.", "DOI": "10.1016/S0165-2478(02)00029-9", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF23", "unstructured": "Nagy N, Maeda A, Bandobashi K, et al. SH2D1A expression in Burkitt lymphoma cells is restricted to EBV positive group I lines and is downregulated in parallel with immunoblastic transformation. Int J Cancer.2002;100: 433-440.", "DOI": "10.1002/ijc.10498", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF24", "unstructured": "Kis LL, Nagy N, Klein G, Klein E. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines. Int J Cancer.2003;104: 658-661.", "DOI": "10.1002/ijc.10986", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF25", "unstructured": "Shaffer AL, Rosenwald A, Staudt LM. Lymphoid malignancies: the dark side of B-cell differentiation. Nat Rev Immunol.2002;2: 920-932.", "DOI": "10.1038/nri953", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF26", "unstructured": "Kuppers R, Schwering I, Brauninger A, Rajewsky K, Hansmann ML. Biology of Hodgkin's lymphoma. Ann Oncol.2002;13(suppl 1): 11-18.", "DOI": "10.1093/annonc/13.S1.11", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF27", "unstructured": "Takata M, Sabe H, Hata A, et al. Tyrosine kinases Lyn and Syk regulate B cell receptor-coupled Ca2+ mobilization through distinct pathways. EMBO J.1994;13: 1341-1349.", "DOI": "10.1002/j.1460-2075.1994.tb06387.x", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF28", "unstructured": "Kurosaki T. Genetic analysis of B cell antigen receptor signaling. Annu Rev Immunol.1999;17: 555-592.", "DOI": "10.1146/annurev.immunol.17.1.555", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF29", "unstructured": "Jaffe ES, Harris NL, Stein H, Vardiman JW, eds: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARS Press, 2001."}, {"key": "2019111701504610100_REF30", "unstructured": "Mavaddat N, Mason DW, Atkinson PD, et al. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J Biol Chem.2000;275: 28100-28109.", "DOI": "10.1074/jbc.M004117200", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF31", "unstructured": "Tatsuo H, Ono N, Yanagi Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol.2001;75: 5842-5850.", "DOI": "10.1128/JVI.75.13.5842-5850.2001", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF32", "unstructured": "Gold MR, Ingham RJ, McLeod SJ, et al. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev.2000;176: 47-68.", "DOI": "10.1034/j.1600-065X.2000.00601.x", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF33", "unstructured": "Ward SG, Cantrell DA. Phosphoinositide 3-kinases in T lymphocyte activation. Curr Opin Immunol.2001;13: 332-338.", "DOI": "10.1016/S0952-7915(00)00223-5", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF34", "unstructured": "Howie D, Simarro M, Sayos J, et al. Molecular dissection of the signaling and costimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated costimulation. Blood.2002;99: 957-965.", "DOI": "10.1182/blood.V99.3.957", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF35", "unstructured": "Kurosaki T. Functional dissection of BCR signaling pathways. Curr Opin Immunol.2000;12: 276-281.", "DOI": "10.1016/S0952-7915(00)00087-X", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF36", "unstructured": "Lossos IS, Alizadeh AA, Eisen MB, et al. Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas. Proc Natl Acad Sci U S A.2000;97: 10209-10213.", "DOI": "10.1073/pnas.180316097", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF37", "unstructured": "Alizadeh AA, Staudt LM. Genomic-scale gene expression profiling of normal and malignant immune cells. Curr Opin Immunol.2000;12: 219-225.", "DOI": "10.1016/S0952-7915(99)00078-3", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF38", "unstructured": "Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature.2000;403: 503-511.", "DOI": "10.1038/35000501", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF39", "unstructured": "Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest.2003;111: 529-537.", "DOI": "10.1172/JCI200316624", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF40", "unstructured": "von Wasielewski S, Franklin J, Fischer R, et al. Nodular sclerosing Hodgkin disease: new grading predicts prognosis in intermediate and advanced stages. Blood.2003;101: 4063-4069.", "DOI": "10.1182/blood-2002-05-1548", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF41", "unstructured": "Bouchon A, Cella M, Grierson HL, Cohen JI, Colonna M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J Immunol.2001;167: 5517-5521.", "DOI": "10.4049/jimmunol.167.10.5517", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF42", "unstructured": "Craxton A, Jiang A, Kurosaki T, Clark EA. Syk and Bruton's tyrosine kinase are required for B cell antigen receptor-mediated activation of the kinase Akt. J Biol Chem.1999;274: 30644-30650.", "DOI": "10.1074/jbc.274.43.30644", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF43", "unstructured": "Schwering I, Brauninger A, Klein U, et al. Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood.2003;101: 1505-1512.", "DOI": "10.1182/blood-2002-03-0839", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF44", "unstructured": "Zheng B, Fiumara P, Li YV, et al. MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival. Blood.2003;102: 1019-1027.", "DOI": "10.1182/blood-2002-11-3507", "doi-asserted-by": "crossref"}, {"key": "2019111701504610100_REF45", "unstructured": "Papadaki T, Stamatopoulos K. Hodgkin disease immunopathogenesis: long-standing questions, recent answers, further directions. Trends Immunol.2003;24: 508-511.", "DOI": "10.1016/S1471-4906(03)00236-9", "doi-asserted-by": "crossref"}], "container-title": ["Blood"], "language": "en", "link": [{"URL": "https://ashpublications.org/blood/article/104/13/4063/19007/The-adaptor-protein-SH2D1A-regulates-signaling", "content-type": "application/pdf", "content-version": "vor", "intended-application": "syndication"}, {"URL": "https://ashpublications.org/blood/article/104/13/4063/19007/The-adaptor-protein-SH2D1A-regulates-signaling", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 11, 17]], "date-time": "2019-11-17T06:51:09Z", "timestamp": 1573973469000}, "score": 41.38497, "issued": {"date-parts": [[2004, 12, 15]]}, "references-count": 45, "journal-issue": {"published-print": {"date-parts": [[2004, 12, 15]]}, "issue": "13"}, "URL": "http://dx.doi.org/10.1182/blood-2004-04-1273", "relation": {"cites": []}, "ISSN": ["0006-4971", "1528-0020"], "issn-type": [{"value": "0006-4971", "type": "print"}, {"value": "1528-0020", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 2]], "date-time": "2019-12-02T08:02:27Z", "timestamp": 1575273747194}, "reference-count": 0, "publisher": "Society for Neuroscience", "issue": "2", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["J. Neurosci."], "published-print": {"date-parts": [[1995, 2, 1]]}, "DOI": "10.1523/jneurosci.15-02-01532.1995", "type": "journal-article", "created": {"date-parts": [[2018, 4, 2]], "date-time": "2018-04-02T18:00:44Z", "timestamp": 1522692044000}, "page": "1532-1544", "source": "Crossref", "is-referenced-by-count": 101, "title": ["Cellular and molecular characterization of a brain-enriched protein tyrosine phosphatase"], "prefix": "10.1523", "volume": "15", "author": [{"given": "LM", "family": "Boulanger", "sequence": "first", "affiliation": []}, {"given": "PJ", "family": "Lombroso", "sequence": "additional", "affiliation": []}, {"given": "A", "family": "Raghunathan", "sequence": "additional", "affiliation": []}, {"given": "MJ", "family": "During", "sequence": "additional", "affiliation": []}, {"given": "P", "family": "Wahle", "sequence": "additional", "affiliation": []}, {"given": "JR", "family": "Naegele", "sequence": "additional", "affiliation": []}], "member": "393", "published-online": {"date-parts": [[1995, 2, 1]]}, "container-title": ["The Journal of Neuroscience"], "language": "en", "link": [{"URL": "https://syndication.highwire.org/content/doi/10.1523/JNEUROSCI.15-02-01532.1995", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 4, 13]], "date-time": "2018-04-13T22:18:45Z", "timestamp": 1523657925000}, "score": 36.708874, "issued": {"date-parts": [[1995, 2, 1]]}, "references-count": 0, "journal-issue": {"published-online": {"date-parts": [[1995, 2, 1]]}, "published-print": {"date-parts": [[1995, 2, 1]]}, "issue": "2"}, "alternative-id": ["10.1523/JNEUROSCI.15-02-01532.1995"], "URL": "http://dx.doi.org/10.1523/jneurosci.15-02-01532.1995", "ISSN": ["0270-6474", "1529-2401"], "issn-type": [{"value": "0270-6474", "type": "print"}, {"value": "1529-2401", "type": "electronic"}], "subject": ["General Neuroscience"]}, {"institution": {"name": "Signaling Pathways Project", "place": ["-"], "acronym": ["SPP"]}, "indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T21:20:50Z", "timestamp": 1575494450884}, "reference-count": 0, "publisher": "Signaling Pathways Project", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1621/jrycek1chw", "type": "dataset", "created": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:32:45Z", "timestamp": 1565364765000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of\u00a0PD173074-regulated and mitogen-activated protein kinase kinase kinase 7 (MAP3K7)-dependent transcriptomes in human MGHU3 blader cancer cells"], "prefix": "10.1621", "author": [{"given": "LM", "family": "Thompson", "sequence": "first", "affiliation": []}], "member": "625", "container-title": ["Signaling Pathways Project Datasets"], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:49:20Z", "timestamp": 1565365760000}, "score": 31.41536, "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1621/jrycek1chw"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T03:44:20Z", "timestamp": 1574135060089}, "reference-count": 25, "publisher": "Springer Science and Business Media LLC", "issue": "3", "license": [{"URL": "http://www.springer.com/tdm", "start": {"date-parts": [[2001, 9, 1]], "date-time": "2001-09-01T00:00:00Z", "timestamp": 999302400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Prostate Cancer Prostatic Dis"], "published-print": {"date-parts": [[2001, 9]]}, "DOI": "10.1038/sj.pcan.4500504", "type": "journal-article", "created": {"date-parts": [[2002, 9, 19]], "date-time": "2002-09-19T22:01:59Z", "timestamp": 1032472919000}, "page": "173-177", "source": "Crossref", "is-referenced-by-count": 3, "title": ["Effects of bicalutamide and leuprolide on prostate-specific antigen (PSA), acid phosphatase (ACP) and prostatic acid phosphatase (PAP) in men with benign prostatic hyperplasia (BPH)"], "prefix": "10.1038", "volume": "4", "author": [{"given": "LM", "family": "Eri", "sequence": "first", "affiliation": []}, {"given": "KJ", "family": "Tveter", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2001, 10, 4]]}, "reference": [{"key": "BF4500504_CR1", "doi-asserted-by": "publisher", "first-page": "61", "DOI": "10.1002/(SICI)1097-0045(19980101)34:1<61::AID-PROS8>3.0.CO;2-N", "volume": "34", "author": "GJCM Kolvenbag", "year": "1998", "unstructured": "Kolvenbag GJCM, Blackledge GRP, Gotting-Smith K Bicalutamide (Casodex\u00ae) in the treatment of prostate cancer: history of clinical development. Prostate 1998 34 61\u201372", "journal-title": "Prostate"}, {"key": "BF4500504_CR2", "doi-asserted-by": "publisher", "first-page": "191", "DOI": "10.1159/000067996", "volume": "36", "author": "C Palmberg", "year": "1999", "unstructured": "Palmberg C, Koivisto P, Visakorpi T, Tammela TLJ PSA decline is an independent prognostic marker in hormonally treated prostate cancer. Eur Urol 1999 36 191\u2013196", "journal-title": "Eur Urol"}, {"key": "BF4500504_CR3", "first-page": "99", "volume": "18", "author": "GT Kennealey", "year": "1991", "unstructured": "Kennealey GT, Furr BJA Use of the nonsteroidal anti-androgen Casodex in advanced prostatic carcinoma. Urol Clin North Am 1991 18 99\u2013110", "journal-title": "Urol Clin North Am"}, {"key": "BF4500504_CR4", "doi-asserted-by": "publisher", "first-page": "47", "DOI": "10.1002/(SICI)1097-0045(19990401)39:1<47::AID-PROS8>3.0.CO;2-X", "volume": "39", "author": "GJCM Kolvenbag", "year": "1999", "unstructured": "Kolvenbag GJCM, Nash A Bicalutamide dosages used in the treatment of prostate cancer. Prostate 1999 39 47\u201353", "journal-title": "Prostate"}, {"key": "BF4500504_CR5", "doi-asserted-by": "publisher", "first-page": "293", "DOI": "10.1016/S0090-4295(97)00497-4", "volume": "51", "author": "M Kojima", "year": "1998", "unstructured": "Kojima M, Troncoso P, Babaian RJ Influence of noncancerous prostatic tissue volume on prostate-specific antigen. Urology 1998 51 293\u2013299", "journal-title": "Urology"}, {"key": "BF4500504_CR6", "doi-asserted-by": "publisher", "first-page": "10", "DOI": "10.1016/0090-4295(89)90147-7", "volume": "34", "author": "AC Levine", "year": "1989", "unstructured": "Levine AC et al Serum prostate-antigen levels in patients with benign prostatic hypertrophy treated with leuprolide. Urology 1989 34 10\u201313", "journal-title": "Urology"}, {"key": "BF4500504_CR7", "doi-asserted-by": "publisher", "first-page": "309", "DOI": "10.1016/S0022-5347(17)38324-6", "volume": "145", "author": "H Matzkin", "year": "1991", "unstructured": "Matzkin H, Chen J, Lewysohn O, Braf Z Treatment of benign prostatic hypertrophy by a long-acting gonadotropin-releasing hormone analogue: 1-year experience. J Urol 1991 145 309\u2013312", "journal-title": "J Urol"}, {"key": "BF4500504_CR8", "doi-asserted-by": "publisher", "first-page": "987", "DOI": "10.1016/S0022-5347(17)41083-4", "volume": "141", "author": "JP Weber", "year": "1989", "unstructured": "Weber JP et al The influence of reversible androgen deprivation on serum prostate-specific antigen levels in men with benign prostatic hyperplasia. J Urol 1989 141 987\u2013992", "journal-title": "J Urol"}, {"key": "BF4500504_CR9", "doi-asserted-by": "publisher", "first-page": "(Suppl 1): 108", "DOI": "10.1159/000474905", "volume": "21", "author": "S Omacini", "year": "1992", "unstructured": "Omacini S et al Relationship between prostatic acid phosphatase and prostate-specific antigen serum levels and prostatic volume in benign prostate hyperplasia. Pitfall on tumor markers assessment in primary prostatic cancer? Eur Urol 1992 21 (Suppl 1): 108\u2013110", "journal-title": "Eur Urol"}, {"key": "BF4500504_CR10", "doi-asserted-by": "publisher", "first-page": "90", "DOI": "10.1016/S0022-5347(17)35406-X", "volume": "150", "author": "LM Eri", "year": "1993", "unstructured": "Eri LM, Tveter KJ A prospective, placebo-controlled study of the antiandrogen Casodex as treatment for patients with benign prostatic hyperplasia. J Urol 1993 150 90\u201394", "journal-title": "J Urol"}, {"key": "BF4500504_CR11", "doi-asserted-by": "publisher", "first-page": "359", "DOI": "10.1016/S0022-5347(17)35483-6", "volume": "150", "author": "LM Eri", "year": "1993", "unstructured": "Eri LM, Tveter KJ A prospective, placebo-controlled study of the luteinizing hormone-releasing hormone agonist leuprolide as treatment for patients with benign prostatic hyperplasia. J Urol 1993 150 359\u2013364", "journal-title": "J Urol"}, {"key": "BF4500504_CR12", "first-page": "376", "volume": "12", "author": "NN Stone", "year": "1991", "unstructured": "Stone NN, Clejan SJ Response of prostate volume, prostate-specific antigen, and testosterone to flutamide in men with benign prostatic hyperplasia. J. Androl 1991 12 376\u2013380", "journal-title": "J. Androl"}, {"key": "BF4500504_CR13", "doi-asserted-by": "publisher", "first-page": "89", "DOI": "10.1002/pros.2990200203", "volume": "20", "author": "H Lepor", "year": "1992", "unstructured": "Lepor H, Machi G The relative efficacy of terazosin versus terazosin and flutamide for the treatment of symptomatic BPH. Prostate 1992 20 89\u201395", "journal-title": "Prostate"}, {"key": "BF4500504_CR14", "doi-asserted-by": "publisher", "first-page": "39", "DOI": "10.1159/000019526", "volume": "33", "author": "CJ Tyrrell", "year": "1998", "unstructured": "Tyrrell CJ et al CasodexTM 10\u2013200\u2005mg daily, used as monotherapy for the treatment of patients with advanced prostate cancer. Eur Urol 1998 33 39\u201353", "journal-title": "Eur Urol"}, {"key": "BF4500504_CR15", "first-page": "13", "volume": "18", "author": "KPJ Delaere", "year": "1991", "unstructured": "Delaere KPJ, Van Thillo EL Flutamide monotherapy as primary treatment in advanced prostatic carcinoma. Semin Oncol 1991 18 (Suppl 1)13\u201318", "journal-title": "Semin Oncol"}, {"key": "BF4500504_CR16", "doi-asserted-by": "publisher", "first-page": "713", "DOI": "10.1016/S0090-4295(96)00013-1", "volume": "47", "author": "J Noldus", "year": "1996", "unstructured": "Noldus J, Ferrari M, Prestigiacomo A, Stamey TA Effect of flutamide and flutamide plus castration on prostate size in patients with previously untreated prostate cancer. Urology 1996 47 713\u2013718", "journal-title": "Urology"}, {"key": "BF4500504_CR17", "doi-asserted-by": "publisher", "first-page": "913", "DOI": "10.1016/S0090-4295(97)00091-5", "volume": "49", "author": "A Brufsky", "year": "1997", "unstructured": "Brufsky A et al Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate. Urology 1997 49 913\u2013920", "journal-title": "Urology"}, {"key": "BF4500504_CR18", "doi-asserted-by": "publisher", "first-page": "745", "DOI": "10.1016/S0090-4295(99)80077-6", "volume": "45", "author": "P Schellhammer", "year": "1999", "unstructured": "Schellhammer P et al A controlled trial of bicalutamide versus flutamide, each in combination with luteinizing hormone-releasing hormone analogue therapy, in patients with advanced prostate cancer. Urology 1999 45 745\u2013752", "journal-title": "Urology"}, {"key": "BF4500504_CR19", "doi-asserted-by": "publisher", "first-page": "1201", "DOI": "10.1016/S0022-5347(17)36860-X", "volume": "148", "author": "JC Presti Jr", "year": "1992", "unstructured": "Presti Jr JC et al Multicenter, randomized, double-blind, placebo controlled study to investigate the effect of finasteride (MK-906) on stage D prostate cancer. J Urol 1992 148 1201\u20131204", "journal-title": "J Urol"}, {"key": "BF4500504_CR20", "doi-asserted-by": "publisher", "first-page": "195", "DOI": "10.1016/S0090-4295(98)00184-8", "volume": "52", "author": "GL Andriole", "year": "1998", "unstructured": "Andriole GL et al Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. Urology 1998 52 195\u2013202", "journal-title": "Urology"}, {"key": "BF4500504_CR21", "doi-asserted-by": "publisher", "first-page": "31", "DOI": "10.1002/pros.2990220105", "volume": "22", "author": "HA Guess", "year": "1993", "unstructured": "Guess HA, Heyse JF, Gormley GJ The effect of finasteride on prostate-specific antigen in men with benign prostatic hyperplasia. Prostate 1993 22 31\u201337", "journal-title": "Prostate"}, {"key": "BF4500504_CR22", "doi-asserted-by": "publisher", "first-page": "1642", "DOI": "10.1016/S0022-5347(01)66734-X", "volume": "154", "author": "NE Fleshner", "year": "1995", "unstructured": "Fleshner NE, Trachtenberg J Combination finasteride and flutamide in advanced carcinoma of the prostate: effective therapy with minimal side effects. J Urology 1995 154 1642\u20131646", "journal-title": "J Urology"}, {"key": "BF4500504_CR23", "doi-asserted-by": "publisher", "first-page": "105", "DOI": "10.1002/(SICI)1097-0045(19990701)40:2<105::AID-PROS6>3.0.CO;2-9", "volume": "40", "author": "R Kirby", "year": "1999", "unstructured": "Kirby R et al on behalf of the International Prostate Health Council (IPHC) Trial Study Group Finasteride in association with either flutamide or goserelin as combination hormonal therapy in patients with stage MI carcinoma of the prostate gland. Prostate 1999 40 105\u2013114", "journal-title": "Prostate"}, {"key": "BF4500504_CR24", "doi-asserted-by": "publisher", "first-page": "208A", "DOI": "10.1097/00005392-199904010-00835", "volume": "161", "author": "R Kranse", "year": "1999", "unstructured": "Kranse R et al Repeated determination of total and free PSA in serum samples when stored at \u221280 degrees Celsius. J Urol 1999 161 208A", "journal-title": "J Urol"}, {"key": "BF4500504_CR25", "doi-asserted-by": "publisher", "first-page": "(Suppl 1A): 44", "DOI": "10.1016/S0090-4295(96)80008-2", "volume": "47", "author": "GRP Blackledge", "year": "1996", "unstructured": "Blackledge GRP High-dose bicalutamide monotherapy for the treatment of prostate cancer. Urology 1996 47 (Suppl 1A): 44\u201347", "journal-title": "Urology"}], "container-title": ["Prostate Cancer and Prostatic Diseases"], "language": "en", "link": [{"URL": "http://www.nature.com/articles/4500504.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500504", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://www.nature.com/articles/4500504.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 4, 15]], "date-time": "2019-04-15T15:28:24Z", "timestamp": 1555342104000}, "score": 29.240276, "issued": {"date-parts": [[2001, 9]]}, "references-count": 25, "journal-issue": {"published-print": {"date-parts": [[2001, 9]]}, "issue": "3"}, "alternative-id": ["BF4500504"], "URL": "http://dx.doi.org/10.1038/sj.pcan.4500504", "relation": {"cites": []}, "ISSN": ["1365-7852", "1476-5608"], "issn-type": [{"value": "1365-7852", "type": "print"}, {"value": "1476-5608", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 12, 1]], "date-time": "2019-12-01T06:41:01Z", "timestamp": 1575182461040}, "reference-count": 0, "publisher": "CSIRO Publishing", "issue": "5", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Reprod. Fertil. Dev."], "published-print": {"date-parts": [[1995]]}, "abstract": "<jats:p>(R,S)-alpha-chlorohydrin-1-phosphate, previously shown to have no anti-glycolytic activity on mature boar sperm in vitro, is a substrate for acid and/or neutral phosphatase(s) that are associated with washed sperm. The high phosphatase activity hydrolyses the ester to alpha-chlorohydrin which undergoes oxidation to (S)-3-chlorolactaldehyde, a specific inhibitor of sperm glyceraldehyde-3-phosphate dehydrogenase and triosephosphate isomerase, thereby exhibiting an anti-glycolytic action.</jats:p>", "DOI": "10.1071/rd9951089", "type": "journal-article", "created": {"date-parts": [[2005, 10, 19]], "date-time": "2005-10-19T01:25:41Z", "timestamp": 1129685141000}, "page": "1089", "source": "Crossref", "is-referenced-by-count": 20, "title": ["Inhibition of glycolysis in boar spermatozoa by alpha-chlorohydrin phosphate appears to be mediated by phosphatase activity"], "prefix": "10.1071", "volume": "7", "author": [{"given": "AR", "family": "Jones", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Porter", "sequence": "additional", "affiliation": []}], "member": "67", "container-title": ["Reproduction, Fertility and Development"], "language": "en", "link": [{"URL": "http://www.publish.csiro.au/RD/pdf/RD9951089", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 23]], "date-time": "2018-11-23T01:22:11Z", "timestamp": 1542936131000}, "score": 26.447502, "issued": {"date-parts": [[1995]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1995]]}, "issue": "5"}, "alternative-id": ["RD9951089"], "URL": "http://dx.doi.org/10.1071/rd9951089", "ISSN": ["1031-3613"], "issn-type": [{"value": "1031-3613", "type": "print"}], "subject": ["Biotechnology", "Developmental Biology", "Animal Science and Zoology", "Genetics", "Molecular Biology", "Endocrinology", "Reproductive Medicine"]}, {"indexed": {"date-parts": [[2019, 11, 27]], "date-time": "2019-11-27T22:05:58Z", "timestamp": 1574892358672}, "reference-count": 111, "publisher": "Elsevier BV", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2019, 7, 1]], "date-time": "2019-07-01T00:00:00Z", "timestamp": 1561939200000}, "delay-in-days": 0, "content-version": "tdm"}], "funder": [{"DOI": "10.13039/501100004742", "name": "National Academy of Sciences of Ukraine", "doi-asserted-by": "publisher", "award": ["0115U002970", "0116U007817"]}], "content-domain": {"domain": ["clinicalkey.jp", "clinicalkey.com", "clinicalkey.es", "clinicalkey.fr", "clinicalkey.com.au", "elsevier.com", "sciencedirect.com"], "crossmark-restriction": true}, "short-container-title": ["Clinical Immunology"], "published-print": {"date-parts": [[2019, 7]]}, "DOI": "10.1016/j.clim.2018.10.015", "type": "journal-article", "created": {"date-parts": [[2018, 10, 25]], "date-time": "2018-10-25T18:58:21Z", "timestamp": 1540493901000}, "page": "14-22", "update-policy": "http://dx.doi.org/10.1016/elsevier_cm_policy", "source": "Crossref", "is-referenced-by-count": 0, "title": ["SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?"], "prefix": "10.1016", "volume": "204", "author": [{"given": "Inna", "family": "Gordiienko", "sequence": "first", "affiliation": []}, {"given": "Larysa", "family": "Shlapatska", "sequence": "additional", "affiliation": []}, {"given": "Larysa", "family": "Kovalevska", "sequence": "additional", "affiliation": []}, {"ORCID": "http://orcid.org/0000-0001-8281-8006", "authenticated-orcid": false, "given": "Svetlana P.", "family": "Sidorenko", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Clinical Immunology"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S1521661618304376?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S1521661618304376?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 9, 20]], "date-time": "2019-09-20T02:45:23Z", "timestamp": 1568947523000}, "score": 26.094595, "issued": {"date-parts": [[2019, 7]]}, "references-count": 111, "alternative-id": ["S1521661618304376"], "URL": "http://dx.doi.org/10.1016/j.clim.2018.10.015", "ISSN": ["1521-6616"], "issn-type": [{"value": "1521-6616", "type": "print"}], "assertion": [{"value": "Elsevier", "name": "publisher", "label": "This article is maintained by"}, {"value": "SLAMF1/CD150 in hematologic malignancies: Silent marker or active player?", "name": "articletitle", "label": "Article Title"}, {"value": "Clinical Immunology", "name": "journaltitle", "label": "Journal Title"}, {"value": "https://doi.org/10.1016/j.clim.2018.10.015", "name": "articlelink", "label": "CrossRef DOI link to publisher maintained version"}, {"value": "article", "name": "content_type", "label": "Content Type"}, {"value": "\u00a9 2018 Published by Elsevier Inc.", "name": "copyright", "label": "Copyright"}]}, {"indexed": {"date-parts": [[2019, 11, 22]], "date-time": "2019-11-22T22:10:42Z", "timestamp": 1574460642912}, "reference-count": 0, "publisher": "CSIRO Publishing", "issue": "1", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Aust. J. Chem."], "published-print": {"date-parts": [[1950]]}, "abstract": "<jats:p>Using mainly silver-magnesium alloys, the\ndeformation of the phases was determined from observations of slip lines and\nrecrystallization behaviour. The relative deformation of the two phases is\ninfluenced both by the total deformation of the alloy and by the volume\nfractions of the phases. When very little of the hard \u03b2 phase is present\nmost of the deformation occurs in the soft \u03b1 crystals and there is\nadditional flow of the matrix around the hard particles. If the proportion of\nthe \u03b2 phase is not greater than 30 per cent. by volume the soft \u03b1\ndeforms more than the \u03b2 for reductions of up to 60 per cent., but for\nheavier reductions the two phases deform more uniformly. When both phases are\npresent in about equal proportions they deform to the same extent.\ufffdThe\nrecrystallization behaviour of the phases in a duplex alloy is affected by the\nstate of order of the phases, and by precipitation occurring in one of the\nphases on annealing the deformed alloy. Experiments were designed to show the\ninfluence of various factors. \n\nAn alloy that is ordered before\ndeformation recrystallizes at a lower temperature than an alloy disordered\nbefore deformation. It is shown that this behaviour is not due to a difference\nin work hardening characteristics. \n\nOn annealing silver-magnesium and\ncopper-zinc alloys quenched before deformation, precipitation of \u03b1 occurs\nin the \u03b2 crystals and the recrystallization temperature of the \u03b2 is\nhigher in these alloys than in slowly cooled alloys. It is shown that\nprecipitation relieves internal stresses in the deformed matrix and thus causes\nthe Increase in recrystallization temperature. \n\nThe general case of recrystallization of\nthe phases in slowly cooled and quenched silver-magnesium alloys is interpreted\nin terms of these results. \n\nThe inhomogeneity of deformation of the\nphases is indicated by their mode of recrystallization. \n\n\n\n\n\n</jats:p>", "DOI": "10.1071/ch9500072", "type": "journal-article", "created": {"date-parts": [[2010, 9, 2]], "date-time": "2010-09-02T02:21:56Z", "timestamp": 1283394116000}, "page": "72", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Deformation and Recrystallization of Alloys containing Two Phases"], "prefix": "10.1071", "volume": "3", "author": [{"given": "LM", "family": "Clarebrough", "sequence": "first", "affiliation": []}], "member": "67", "container-title": ["Australian Journal of Chemistry"], "language": "en", "link": [{"URL": "http://www.publish.csiro.au/CH/pdf/CH9500072", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 11, 21]], "date-time": "2018-11-21T06:59:43Z", "timestamp": 1542783583000}, "score": 25.874866, "issued": {"date-parts": [[1950]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1950]]}, "issue": "1"}, "alternative-id": ["CH9500072"], "URL": "http://dx.doi.org/10.1071/ch9500072", "ISSN": ["0004-9425"], "issn-type": [{"value": "0004-9425", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:48:38Z", "timestamp": 1574153318394}, "reference-count": 0, "publisher": "Bioscientifica", "content-domain": {"domain": ["jme.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2003, 4, 1]]}, "abstract": "<jats:p>A growing body of data supports the conclusion that G protein-coupled receptors can regulate cellular growth and differentiation by controlling the activity of MAP kinases. The activation of heterotrimeric G protein pools initiates a complex network of signals leading to MAP kinase activation that frequently involves cross-talk between G protein-coupled receptors and receptor tyrosine kinases or focal adhesions. The dominant mechanism of MAP kinase activation varies significantly between receptor and cell type. Moreover, the mechanism of MAP kinase activation has a substantial impact on MAP kinase function. Some signals lead to the targeting of activated MAP kinase to specific extranuclear locations, while others activate a MAP kinase pool that is free to translocate to the nucleus and contribute to a mitogenic response.</jats:p>", "DOI": "10.1677/jme.0.0300117", "type": "journal-article", "created": {"date-parts": [[2004, 12, 2]], "date-time": "2004-12-02T23:43:59Z", "timestamp": 1102031039000}, "page": "117-126", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 80, "title": ["'Location, location, location': activation and targeting of MAP kinases by G protein-coupled receptors"], "prefix": "10.1530", "author": [{"given": "LM", "family": "Luttrell", "sequence": "first", "affiliation": []}], "member": "416", "container-title": ["Journal of Molecular Endocrinology"], "link": [{"URL": "https://jme.bioscientifica.com/view/journals/jme/30/2/117.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T13:49:02Z", "timestamp": 1550238542000}, "score": 23.656147, "issued": {"date-parts": [[2003, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1677/jme.0.0300117", "ISSN": ["0952-5041", "1479-6813"], "issn-type": [{"value": "0952-5041", "type": "print"}, {"value": "1479-6813", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T02:41:13Z", "timestamp": 1574304073541}, "publisher-location": "Chichester, UK", "reference-count": 0, "publisher": "John Wiley & Sons, Ltd", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1002/14651858.cd006586", "type": "reference-entry", "created": {"date-parts": [[2007, 7, 3]], "date-time": "2007-07-03T14:37:15Z", "timestamp": 1183473435000}, "source": "Crossref", "is-referenced-by-count": 1, "title": ["Oral contraceptives containing drospirenone for premenstrual syndrome"], "prefix": "10.1002", "author": [{"given": "LM", "family": "Lopez", "sequence": "first", "affiliation": []}, {"given": "A", "family": "Kaptein", "sequence": "additional", "affiliation": []}, {"given": "FM", "family": "Helmerhorst", "sequence": "additional", "affiliation": []}], "member": "311", "published-online": {"date-parts": [[2007, 7, 18]]}, "container-title": ["Cochrane Database of Systematic Reviews"], "link": [{"URL": "https://onlinelibrary.wiley.com/doi/full/10.1002/14651858.CD006586", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2018, 8, 5]], "date-time": "2018-08-05T02:56:12Z", "timestamp": 1533437772000}, "score": 22.564022, "editor": [{"given": "Laureen", "family": "Lopez", "sequence": "additional", "affiliation": []}], "issued": {"date-parts": [[2007, 7, 18]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1002/14651858.cd006586", "ISSN": ["1465-1858"], "issn-type": [{"value": "1465-1858", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T04:12:20Z", "timestamp": 1574309540874}, "reference-count": 4, "publisher": "Elsevier BV", "issue": "9683", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[2009, 7, 1]], "date-time": "2009-07-01T00:00:00Z", "timestamp": 1246406400000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["The Lancet"], "published-print": {"date-parts": [[2009, 7]]}, "DOI": "10.1016/s0140-6736(09)61233-2", "type": "journal-article", "created": {"date-parts": [[2009, 7, 3]], "date-time": "2009-07-03T09:07:13Z", "timestamp": 1246612033000}, "page": "26", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Rosuvastatin, C-reactive protein, LDL cholesterol, and the JUPITER trial"], "prefix": "10.1016", "volume": "374", "author": [{"given": "J", "family": "Segura", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Ruilope", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["The Lancet"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:S0140673609612332?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:S0140673609612332?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2018, 12, 18]], "date-time": "2018-12-18T16:23:01Z", "timestamp": 1545150181000}, "score": 22.396896, "issued": {"date-parts": [[2009, 7]]}, "references-count": 4, "journal-issue": {"published-print": {"date-parts": [[2009, 7]]}, "issue": "9683"}, "alternative-id": ["S0140673609612332"], "URL": "http://dx.doi.org/10.1016/s0140-6736(09)61233-2", "ISSN": ["0140-6736"], "issn-type": [{"value": "0140-6736", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 12, 4]], "date-time": "2019-12-04T08:32:48Z", "timestamp": 1575448368148}, "reference-count": 0, "publisher": "Spandidos Publications", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Int J Oncol"], "DOI": "10.3892/ijo.4.4.915", "type": "journal-article", "created": {"date-parts": [[2014, 3, 10]], "date-time": "2014-03-10T07:20:36Z", "timestamp": 1394436036000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["ALTERATIONS IN INTEGRIN AND BASEMENT-MEMBRANE PROTEIN EXPRESSION BY MALIGNANT BREAST CELLS"], "prefix": "10.3892", "author": [{"given": "LM", "family": "BERGSTRAESSER", "sequence": "first", "affiliation": []}, {"given": "SA", "family": "WEITZMAN", "sequence": "additional", "affiliation": []}], "member": "2249", "published-online": {"date-parts": [[1994, 4, 1]]}, "container-title": ["International Journal of Oncology"], "link": [{"URL": "https://spandidos-publications.com/10.3892/ijo.4.4.915/download", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 27]], "date-time": "2017-04-27T09:56:57Z", "timestamp": 1493287017000}, "score": 22.396896, "issued": {"date-parts": [[1994, 4, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.3892/ijo.4.4.915", "ISSN": ["1019-6439", "1791-2423"], "issn-type": [{"value": "1019-6439", "type": "print"}, {"value": "1791-2423", "type": "electronic"}], "subject": ["Cancer Research", "Oncology"]}, {"institution": {"name": "Signaling Pathways Project", "place": ["-"], "acronym": ["SPP"]}, "indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:55:41Z", "timestamp": 1574722541200}, "reference-count": 0, "publisher": "Signaling Pathways Project", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1621/yjql81zn2w", "type": "dataset", "created": {"date-parts": [[2015, 8, 25]], "date-time": "2015-08-25T20:27:04Z", "timestamp": 1440534424000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of the glucocorticoid receptor (GR/NR3C1)-regulated transcriptome in mouse skin"], "prefix": "10.1621", "author": [{"given": "LM", "family": "Sevilla", "sequence": "first", "affiliation": []}], "member": "625", "container-title": ["Signaling Pathways Project Datasets"], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:34:07Z", "timestamp": 1565364847000}, "score": 22.095465, "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1621/yjql81zn2w"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T06:39:35Z", "timestamp": 1574145575455}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2-3", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 1, 1]], "date-time": "1992-01-01T00:00:00Z", "timestamp": 694224000000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Biomedicine & Pharmacotherapy"], "published-print": {"date-parts": [[1992, 1]]}, "DOI": "10.1016/0753-3322(92)90287-h", "type": "journal-article", "created": {"date-parts": [[2002, 12, 14]], "date-time": "2002-12-14T02:56:22Z", "timestamp": 1039834582000}, "page": "128-129", "source": "Crossref", "is-referenced-by-count": 0, "title": ["Phosphorylation of phospholipase-\u03b3 l, profilin and tyrosine"], "prefix": "10.1016", "volume": "46", "author": [{"given": "LM", "family": "Machesky", "sequence": "first", "affiliation": []}], "member": "78", "container-title": ["Biomedicine & Pharmacotherapy"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:075333229290287H?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:075333229290287H?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 4, 1]], "date-time": "2019-04-01T21:54:36Z", "timestamp": 1554155676000}, "score": 21.494692, "issued": {"date-parts": [[1992, 1]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 1]]}, "issue": "2-3"}, "alternative-id": ["075333229290287H"], "URL": "http://dx.doi.org/10.1016/0753-3322(92)90287-h", "ISSN": ["0753-3322"], "issn-type": [{"value": "0753-3322", "type": "print"}]}, {"institution": {"name": "Signaling Pathways Project", "place": ["-"], "acronym": ["SPP"]}, "indexed": {"date-parts": [[2019, 11, 25]], "date-time": "2019-11-25T22:55:41Z", "timestamp": 1574722541067}, "reference-count": 0, "publisher": "Signaling Pathways Project", "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1621/nazeswn5o3", "type": "dataset", "created": {"date-parts": [[2015, 8, 25]], "date-time": "2015-08-25T20:27:04Z", "timestamp": 1440534424000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Analysis of peroxisome proliferator activated receptor-\u03b1 (PPAR\u03b1/Ppara)-dependent, PPAR\u03b1 agonist-regulated transcriptomes in mouse liver"], "prefix": "10.1621", "author": [{"given": "LM", "family": "Sanderson", "sequence": "first", "affiliation": []}], "member": "625", "container-title": ["Signaling Pathways Project Datasets"], "deposited": {"date-parts": [[2019, 8, 9]], "date-time": "2019-08-09T15:33:36Z", "timestamp": 1565364816000}, "score": 21.223286, "issued": {"date-parts": [[null]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1621/nazeswn5o3"}, {"indexed": {"date-parts": [[2019, 11, 20]], "date-time": "2019-11-20T21:19:10Z", "timestamp": 1574284750375}, "publisher-location": "100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA 19428-2959", "reference-count": 0, "publisher": "ASTM International", "isbn-type": [{"value": "9780803114265", "type": "print"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "DOI": "10.1520/stp20166s", "type": "book-chapter", "created": {"date-parts": [[2009, 3, 9]], "date-time": "2009-03-09T20:45:48Z", "timestamp": 1236631548000}, "page": "320-320-10", "source": "Crossref", "is-referenced-by-count": 1, "title": ["Analysis of Composite Material Containing Defects"], "prefix": "10.1520", "author": [{"given": "RS", "family": "Frankle", "sequence": "first", "affiliation": []}, {"given": "DR", "family": "Jones", "sequence": "additional", "affiliation": []}, {"given": "BL", "family": "Roberts", "sequence": "additional", "affiliation": []}, {"given": "LM", "family": "Shusto", "sequence": "additional", "affiliation": []}], "member": "381", "container-title": ["Composite Materials: Testing and Design (Tenth Volume)"], "deposited": {"date-parts": [[2015, 4, 7]], "date-time": "2015-04-07T19:00:51Z", "timestamp": 1428433251000}, "score": 21.09576, "issued": {"date-parts": [[null]]}, "ISBN": ["9780803114265"], "references-count": 0, "URL": "http://dx.doi.org/10.1520/stp20166s"}, {"indexed": {"date-parts": [[2019, 11, 23]], "date-time": "2019-11-23T09:52:45Z", "timestamp": 1574502765293}, "reference-count": 0, "publisher": "Springer Science and Business Media LLC", "issue": "S2", "license": [{"URL": "http://creativecommons.org/licenses/by/2.0", "start": {"date-parts": [[2012, 9, 1]], "date-time": "2012-09-01T00:00:00Z", "timestamp": 1346457600000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Retrovirology"], "published-print": {"date-parts": [[2012, 9]]}, "DOI": "10.1186/1742-4690-9-s2-p339", "type": "journal-article", "created": {"date-parts": [[2012, 9, 13]], "date-time": "2012-09-13T10:17:10Z", "timestamp": 1347531430000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Different biological activity of CD154-SIVgp41 fusion protein vaccine component in na\u00efve or pre-immune individuals"], "prefix": "10.1186", "volume": "9", "author": [{"given": "LM", "family": "Smith", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Parodi", "sequence": "additional", "affiliation": []}, {"given": "VL", "family": "Hodora", "sequence": "additional", "affiliation": []}, {"given": "LD", "family": "Giavedoni", "sequence": "additional", "affiliation": []}], "member": "297", "published-online": {"date-parts": [[2012, 9, 13]]}, "container-title": ["Retrovirology"], "language": "en", "link": [{"URL": "http://link.springer.com/content/pdf/10.1186/1742-4690-9-S2-P339.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/article/10.1186/1742-4690-9-S2-P339/fulltext.html", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "http://link.springer.com/content/pdf/10.1186/1742-4690-9-S2-P339.pdf", "content-type": "application/pdf", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2019, 1, 22]], "date-time": "2019-01-22T04:09:23Z", "timestamp": 1548130163000}, "score": 21.090588, "issued": {"date-parts": [[2012, 9]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2012, 9]]}, "issue": "S2"}, "alternative-id": ["3310"], "URL": "http://dx.doi.org/10.1186/1742-4690-9-s2-p339", "ISSN": ["1742-4690"], "issn-type": [{"value": "1742-4690", "type": "electronic"}], "article-number": "P339"}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:46:13Z", "timestamp": 1574153173255}, "reference-count": 0, "publisher": "Elsevier BV", "issue": "2", "license": [{"URL": "https://www.elsevier.com/tdm/userlicense/1.0/", "start": {"date-parts": [[1992, 7, 1]], "date-time": "1992-07-01T00:00:00Z", "timestamp": 709948800000}, "delay-in-days": 0, "content-version": "tdm"}], "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["Regulatory Peptides"], "published-print": {"date-parts": [[1992, 7]]}, "DOI": "10.1016/0167-0115(92)90225-j", "type": "journal-article", "created": {"date-parts": [[2003, 2, 12]], "date-time": "2003-02-12T14:04:12Z", "timestamp": 1045058652000}, "page": "154", "source": "Crossref", "is-referenced-by-count": 0, "title": ["NSAID damage to the gastric mucosa up-regulates expression of a protein related structurally to the skin peptide family PGLa/PYLa"], "prefix": "10.1016", "volume": "40", "author": [{"given": "AS", "family": "Giraud", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Parker", "sequence": "additional", "affiliation": []}], "member": "78", "container-title": ["Regulatory Peptides"], "language": "en", "link": [{"URL": "https://api.elsevier.com/content/article/PII:016701159290225J?httpAccept=text/xml", "content-type": "text/xml", "content-version": "vor", "intended-application": "text-mining"}, {"URL": "https://api.elsevier.com/content/article/PII:016701159290225J?httpAccept=text/plain", "content-type": "text/plain", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 3, 27]], "date-time": "2019-03-27T19:21:39Z", "timestamp": 1553714499000}, "score": 20.934029, "issued": {"date-parts": [[1992, 7]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[1992, 7]]}, "issue": "2"}, "alternative-id": ["016701159290225J"], "URL": "http://dx.doi.org/10.1016/0167-0115(92)90225-j", "ISSN": ["0167-0115"], "issn-type": [{"value": "0167-0115", "type": "print"}]}, {"indexed": {"date-parts": [[2019, 11, 19]], "date-time": "2019-11-19T08:48:34Z", "timestamp": 1574153314341}, "reference-count": 0, "publisher": "Bioscientifica", "content-domain": {"domain": ["jme.bioscientifica.com"], "crossmark-restriction": true}, "published-print": {"date-parts": [[2004, 2, 1]]}, "abstract": "<jats:p>Expression of the gonadotropin genes has been shown to be modulated by pharmacological or physiological activators of both the protein kinase C (PKC) and the cAMP second messenger signaling pathways. Over the past few years, a substantial amount of progress has been made in the identification and characterization of the transcription factors and cognate cis-elements which mediate the PKC response in the LH beta-subunit (LHbeta) gene. In contrast, little is known regarding the molecular mechanisms which mediate cAMP-mediated regulation of this gene. Using pituitary cell lines, we now demonstrate that rat LHbeta gene promoter activity is stimulated following activation of the cAMP system by the adenylate cyclase activating agent, forskolin, or by the peptide, pituitary adenylate cyclase-activating peptide. The forskolin response was eliminated with mutation of a previously identified 3' cis-acting element for the early growth response protein-1 (Egr-1) when evaluated in the context of region -207/+5 of the LHbeta gene. Activation of the cAMP system increased Egr-1 gene promoter activity, Egr-1 protein levels and Egr-1 binding to the LHbeta gene promoter, supporting the role of this transcription factor in mediating the cAMP response. Analysis of a longer LHbeta promoter construct (-797/+5) revealed additional contribution by upstream Sp1 DNA-regulatory regions. Of interest, forskolin-induced stimulation of LHbeta gene promoter activity was observed to increase synergistically with introduction of the transcription factor, steroidogenic factor-1 (SF-1). Although SF-1 is a critical mediator of the cAMP response in other genes, mutation of the SF-1 DNA-binding sites in the rat LHbeta gene did not alter the forskolin response nor did forskolin increase SF-1 protein levels in a gonadotrope cell line. In a further set of experiments, it was determined that forskolin-responsiveness was maintained following mutation of the previously defined homeobox-binding element at position -100. We conclude that both Egr-1 and Sp1 contribute to cAMP-dependent transcription of the rat LHbeta gene promoter. While SF-1 does not act independently to mediate the cAMP/PKA response, SF-1 is important for magnification of this response.</jats:p>", "DOI": "10.1677/jme.0.0320291", "type": "journal-article", "created": {"date-parts": [[2004, 12, 2]], "date-time": "2004-12-02T23:43:59Z", "timestamp": 1102031039000}, "page": "291-306", "update-policy": "http://dx.doi.org/10.1530/crossmarkpolicy-1", "source": "Crossref", "is-referenced-by-count": 21, "title": ["The cAMP signaling system regulates LHbeta gene expression: roles of early growth response protein-1, SP1 and steroidogenic factor-1"], "prefix": "10.1530", "author": [{"given": "CD", "family": "Horton", "sequence": "first", "affiliation": []}, {"given": "LM", "family": "Halvorson", "sequence": "additional", "affiliation": []}], "member": "416", "container-title": ["Journal of Molecular Endocrinology"], "link": [{"URL": "https://jme.bioscientifica.com/view/journals/jme/32/1/291.xml", "content-type": "text/html", "content-version": "vor", "intended-application": "text-mining"}], "deposited": {"date-parts": [[2019, 2, 15]], "date-time": "2019-02-15T13:52:49Z", "timestamp": 1550238769000}, "score": 20.934029, "issued": {"date-parts": [[2004, 2, 1]]}, "references-count": 0, "URL": "http://dx.doi.org/10.1677/jme.0.0320291", "ISSN": ["0952-5041", "1479-6813"], "issn-type": [{"value": "0952-5041", "type": "print"}, {"value": "1479-6813", "type": "electronic"}]}, {"indexed": {"date-parts": [[2019, 11, 21]], "date-time": "2019-11-21T13:29:39Z", "timestamp": 1574342979410}, "reference-count": 0, "publisher": "Cambridge University Press (CUP)", "issue": "S02", "content-domain": {"domain": [], "crossmark-restriction": false}, "short-container-title": ["MAM"], "published-print": {"date-parts": [[2007, 8]]}, "DOI": "10.1017/s143192760707924x", "type": "journal-article", "created": {"date-parts": [[2008, 1, 4]], "date-time": "2008-01-04T10:12:44Z", "timestamp": 1199441564000}, "source": "Crossref", "is-referenced-by-count": 0, "title": ["Role of the Intermediate Filament (IF) Protein, Synemin, in Regulation of Formation of Cell-Cell Adhesion  Sites in Cardiac Myocytes"], "prefix": "10.1017", "volume": "13", "author": [{"given": "LM", "family": "Lund", "sequence": "first", "affiliation": []}, {"given": "M", "family": "Bond", "sequence": "additional", "affiliation": []}], "member": "56", "published-online": {"date-parts": [[2007, 8, 5]]}, "container-title": ["Microscopy and Microanalysis"], "language": "en", "link": [{"URL": "https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S143192760707924X", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking"}], "deposited": {"date-parts": [[2017, 4, 22]], "date-time": "2017-04-22T23:40:20Z", "timestamp": 1492904420000}, "score": 20.934029, "issued": {"date-parts": [[2007, 8]]}, "references-count": 0, "journal-issue": {"published-print": {"date-parts": [[2007, 8]]}, "issue": "S02"}, "alternative-id": ["S143192760707924X"], "URL": "http://dx.doi.org/10.1017/s143192760707924x", "ISSN": ["1431-9276", "1435-8115"], "issn-type": [{"value": "1431-9276", "type": "print"}, {"value": "1435-8115", "type": "electronic"}]}], "items-per-page": 20, "query": {"start-index": 0, "search-terms": null}}}